 |
|  |
Nov-20-17 | Initiated |
H.C. Wainwright |
Buy |
$3 |
|
|
 |
Feb-13-19 03:45PM | AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome Zacks Small Cap Research -21.67% |
Feb-11-19 04:15PM | Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update PR Newswire |
02:30PM | Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
Feb-04-19 02:49PM | Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019 PR Newswire |
Jan-18-19 07:35AM | Market Trends Toward New Normal in Roper Technologies, The AES, D.R. Horton, Forrester Research, Aethlon Medical, and CyberOptics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
Dec-13-18 08:29AM | Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer PR Newswire |
Nov-28-18 06:50AM | Todays Research Reports on Stocks to Watch: Arsanis and Aethlon Medical ACCESSWIRE |
Nov-27-18 01:30PM | AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD Zacks Small Cap Research +25.64% |
10:10AM | The Reason Healthcare Stocks Are Being Called Home By Investors ACCESSWIRE |
07:21AM | Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration PR Newswire |
Nov-12-18 09:45AM | AEMD: Pivot Towards Cancer Makes Sense. FDA Filing For Breakthrough Device in Cancer Zacks Small Cap Research |
08:15AM | Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
Nov-06-18 04:15PM | Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results PR Newswire |
Nov-01-18 08:30AM | Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018 PR Newswire |
Oct-29-18 11:59AM | Aethlon Medical to Present at the NYC Oncology Conference PR Newswire |
Oct-18-18 09:25AM | Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire |
Oct-16-18 08:15AM | Aethlon Medical to Present at the 2018 BIO Investor Forum PR Newswire |
Oct-09-18 01:06PM | How Financially Strong Is Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St. |
Sep-18-18 08:46AM | Aethlon Medical Receives National Cancer Institute Award PR Newswire |
Aug-28-18 09:15AM | AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance Zacks Small Cap Research |
Aug-27-18 08:00AM | Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
Aug-08-18 04:15PM | Aethlon Medical Announces First Quarter Fiscal Year 2019 Results PR Newswire |
02:30PM | Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
Aug-02-18 08:15AM | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018 PR Newswire |
Jun-27-18 09:15AM | Loss-Making Aethlon Medical Inc (NASDAQ:AEMD) Expected To Breakeven Simply Wall St. |
Jun-25-18 09:15AM | Guy Cipriani Joins Aethlon Medical's Board of Directors PR Newswire |
Jun-21-18 07:55AM | New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
Jun-13-18 09:30AM | AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway Zacks Small Cap Research |
Jun-08-18 04:15PM | Aethlon Medical Announces Fiscal 2018 Results PR Newswire +5.38% |
May-31-18 08:45AM | Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018 PR Newswire |
May-25-18 10:49AM | Are Aethlon Medical Incs (NASDAQ:AEMD) Interest Costs Too High? Simply Wall St. |
May-01-18 07:55AM | Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical Future Expectations, Projections Moving into 2018 GlobeNewswire |
Apr-20-18 01:00PM | GVC Capital and Trickle Research Announce Presenter Schedule for Rocky Mountain MicroCap Conference II in Denver on April 24, 2018 ACCESSWIRE |
Mar-22-18 08:00AM | Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix PR Newswire -7.09% |
Mar-19-18 08:25AM | Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -11.05% |
Feb-12-18 06:32AM | Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting PR Newswire +6.94% |
Feb-06-18 10:00AM | AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset Zacks Small Cap Research +9.28% |
Feb-01-18 04:15PM | Aethlon Medical Announces Fiscal 2018 Third Quarter Results PR Newswire |
Jan-29-18 08:15AM | Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018 PR Newswire +6.79% |
Jan-23-18 08:15AM | Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes PR Newswire |
Jan-19-18 06:05PM | Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St. |
Jan-18-18 07:49AM | Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections PR Newswire |
Jan-17-18 08:15AM | Market Trends Toward New Normal in FTD Companies, Acuity Brands, MINDBODY, Actinium Pharmaceuticals, XG Technology, and Aethlon Medical Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
Jan-10-18 09:01AM | Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors PR Newswire |
Jan-07-18 04:18PM | Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets Benzinga |
Dec-27-17 07:55PM | How Does Aethlon Medical Incs (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance? Simply Wall St. |
Nov-29-17 07:45AM | Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board PR Newswire |
Nov-21-17 10:49AM | What Investors Should Know About Aethlon Medical Incs (AEMD) Financial Strength Simply Wall St. |
Nov-09-17 12:58PM | Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors PR Newswire +10.82% |
Nov-08-17 12:00PM | AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research -5.99% |
Nov-02-17 04:15PM | Aethlon Medical Announces Fiscal 2018 Second Quarter Results PR Newswire |
11:00AM | Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
Oct-30-17 07:30AM | Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017 PR Newswire |
Oct-23-17 08:00AM | AEMD: NCI Cancer Grant, FDAs Real World Data Zacks Small Cap Research |
Oct-18-17 07:00AM | Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE |
Oct-16-17 07:15AM | iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire |
07:15AM | Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire |
Oct-12-17 10:14AM | How Does Aethlon Medical Inc (AEMD)s Prospect Stack Up Next To Its Healthcare Peers? Simply Wall St. |
Oct-11-17 08:15AM | Aethlon Medical to Present at the 2017 BIO Investor Forum PR Newswire |
Oct-10-17 01:27PM | Aethlon Medical Announces Compliance With Nasdaq Listing Criteria PR Newswire |
Oct-02-17 06:00AM | Aethlon Medical Announces Pricing of $6 Million Public Offering PR Newswire -37.66% |
Sep-14-17 07:30AM | Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire |
Sep-13-17 08:20AM | Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22% |
Sep-12-17 07:30AM | Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13% |
Sep-11-17 08:51PM | Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67% |
Sep-06-17 09:12AM | Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38% |
Aug-21-17 10:00AM | AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research |
Aug-11-17 09:02AM | Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes |
Aug-10-17 04:15PM | Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56% |
01:00PM | Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE |
Aug-03-17 07:29PM | ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube |
08:00AM | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire |
Jul-19-17 07:11AM | Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire |
Jul-07-17 07:00AM | Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire |
Jul-03-17 02:46PM | ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube |
Jun-30-17 03:00PM | AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research |
12:50PM | Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube |
Jun-28-17 04:15PM | Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23% |
Jun-26-17 08:15AM | Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire |
Jun-14-17 08:00AM | Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00% |
Jun-06-17 08:00AM | Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire |
May-24-17 08:00AM | Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24% |
Apr-28-17 11:00AM | AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research |
Apr-24-17 09:25AM | Aethlon Medical Releases Shareholder Update PR Newswire |
Apr-04-17 09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire -19.47% |
09:03AM | Aethlon Medical Discloses Tech Nation Interview On National Public Radio |
Mar-31-17 09:17AM | AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of |
Mar-21-17 02:50PM | AETHLON MEDICAL INC Files SEC form 8-K, Other Events |
Mar-14-17 05:17PM | AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.59% |
Mar-13-17 07:15AM | Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire +31.74% |
Mar-08-17 09:25AM | Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire |
Mar-01-17 09:25AM | Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire |
Feb-24-17 09:25AM | Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire |
Feb-22-17 09:25AM | Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire |
Feb-16-17 01:04PM | AETHLON MEDICAL INC Financials |
Feb-15-17 09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research |
09:00AM | AEMD: FDA Discussions Regarding U.S. Clearance Pathway |
Feb-10-17 05:18PM | AETHLON MEDICAL INC Files SEC form 10-Q, Quarterly Report -9.62% |
04:15PM | Aethlon Medical Announces Fiscal 2017 Third Quarter Results PR Newswire |
07:07AM | Q3 2017 Aethlon Medical Inc Earnings Release - After Market Close |
|
|
|
 |
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fink Benjamin Matthew | EVP, Finance and CFO | Feb 13 | Option Exercise | 0.00 | 917 | 0 | 20,119 | Feb 14 05:02 PM | REEVES ROBERT K | EVP | Nov 14 | Option Exercise | 0.00 | 6,504 | 0 | 133,409 | Nov 16 05:02 PM | Champion Christopher O | SVP, CAO and Controller | Nov 14 | Option Exercise | 0.00 | 2,775 | 0 | 13,809 | Nov 16 04:44 PM | WALKER R A | Chairman & CEO | Nov 14 | Option Exercise | 0.00 | 19,251 | 0 | 236,816 | Nov 16 04:35 PM | McMillian Amanda M. | EVP and General Counsel | Nov 14 | Option Exercise | 0.00 | 3,469 | 0 | 19,615 | Nov 16 04:31 PM | Ingram Mitchell W | EVP, Intl, DW & Exploration | Nov 14 | Option Exercise | 0.00 | 7,718 | 0 | 53,746 | Nov 16 04:27 PM | GWIN ROBERT G | President | Nov 14 | Option Exercise | 0.00 | 7,718 | 0 | 74,243 | Nov 16 04:23 PM | Brown Daniel E | EVP, US Onshore Operations | Nov 14 | Option Exercise | 0.00 | 7,718 | 0 | 29,307 | Nov 16 04:16 PM | WALKER R A | Chairman, President & CEO | Nov 10 | Option Exercise | 0.00 | 14,951 | 0 | 222,946 | Nov 14 05:29 PM | GWIN ROBERT G | EVP, Finance & CFO | Nov 10 | Option Exercise | 0.00 | 5,994 | 0 | 69,357 | Nov 14 05:22 PM | Champion Christopher O | SVP, CAO and Controller | Nov 10 | Option Exercise | 0.00 | 2,020 | 0 | 11,499 | Nov 14 05:17 PM | Brown Daniel E | EVP, US Onshore Operations | Nov 10 | Option Exercise | 0.00 | 3,098 | 0 | 22,286 | Nov 14 05:12 PM | REEVES ROBERT K | EVP and CAO | Nov 10 | Option Exercise | 0.00 | 4,674 | 0 | 128,584 | Nov 14 05:07 PM | McMillian Amanda M. | EVP and General Counsel | Nov 10 | Option Exercise | 0.00 | 2,424 | 0 | 16,705 | Nov 14 05:02 PM | Ingram Mitchell W | EVP, Intl, DW & Exploration | Nov 10 | Option Exercise | 0.00 | 5,994 | 0 | 48,329 | Nov 14 04:30 PM | Ingram Mitchell W | EVP, Intl, DW & Exploration | Nov 01 | Option Exercise | 0.00 | 19,936 | 0 | 48,842 | Nov 05 04:33 PM | GWIN ROBERT G | EVP, Finance & CFO | Oct 26 | Option Exercise | 0.00 | 5,375 | 0 | 66,333 | Oct 30 05:23 PM | McMillian Amanda M. | EVP and General Counsel | Oct 26 | Option Exercise | 0.00 | 1,691 | 0 | 14,662 | Oct 30 05:19 PM | Champion Christopher O | SVP, CAO and Controller | Oct 26 | Option Exercise | 0.00 | 1,691 | 0 | 9,865 | Oct 30 05:15 PM | REEVES ROBERT K | EVP and CAO | Oct 26 | Option Exercise | 0.00 | 4,191 | 0 | 125,512 | Oct 30 05:11 PM | WALKER R A | Chairman, President & CEO | Oct 26 | Option Exercise | 0.00 | 13,403 | 0 | 213,118 | Oct 30 05:05 PM | Brown Daniel E | EVP, US Onshore Operations | Oct 26 | Option Exercise | 0.00 | 2,053 | 0 | 19,649 | Oct 30 05:01 PM | Champion Christopher O | SVP, CAO and Controller | Jun 01 | Option Exercise | 0.00 | 1,491 | 0 | 8,505 | Jun 05 04:54 PM | Leyendecker Ernest A. III | EVP | Jun 01 | Option Exercise | 0.00 | 21,675 | 0 | 43,461 | Jun 05 04:43 PM |
|
 |
|
 |
|